The pathogenic phenotypes commonly found in Rogdi- and SLC13A5-associated KTS gives rise to the intriguing possibility that these two genes might work together to control the intracellular levels of citrate65. Here, SLC13A5 is linked to angioosteohypertrophic syndrome.